GLOPHARMA
0819.017.223 · rovalta.com · 23/09/2026
GLOPHARMA
Overview
What does GLOPHARMA do?
GLOPHARMA is a Private limited company incorporated in 2009. Its main activity is: Activities of holding companies. Its registered office is in Zwevegem.
8550 Zwevegem · FlandreSee on map
Trend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||
| Gross margin | 404,7 k € | +11.3% | 363,6 k € | -8.2% | 396,1 k € | +0.6% | 393,8 k € | -9.4% | 434,4 k € | +60.3% | 271,1 k € | -20.3% | 340,1 k € | -3.2% | 351,5 k € | -7.8% | 381,4 k € | +13.2% | 337,1 k € | +249% | 96,7 k € | +103% | 47,7 k € | +16.1% | 41,1 k € | +4.8% | 39,2 k € | +27.6% | 30,7 k € | -4.7% | 32,2 k € |
| EBITDA | 402,9 k € | +11.6% | 360,9 k € | -8.6% | 394,6 k € | +0.6% | 392,4 k € | -9.4% | 433,1 k € | +60.6% | 269,7 k € | -20.6% | 339,7 k € | -3.1% | 350,6 k € | -7.1% | 377,5 k € | +12.4% | 335,8 k € | +254% | 94,9 k € | +101% | 47,2 k € | +16.3% | 40,6 k € | +6.1% | 38,3 k € | +28.3% | 29,8 k € | -5.2% | 31,5 k € |
| Operating result | 387,8 k € | +11.2% | 348,7 k € | -8.8% | 382,5 k € | +0.4% | 380,9 k € | -9.6% | 421,4 k € | +61.5% | 260,9 k € | -19.9% | 325,8 k € | -4.6% | 341,5 k € | -5.9% | 362,9 k € | +13.2% | 320,7 k € | +302% | 79,8 k € | +94.8% | 40,9 k € | +18.7% | 34,5 k € | +1.6% | 33,9 k € | +39.3% | 24,4 k € | -2.4% | 24,9 k € |
| Net result | 222,3 k € | +8.7% | 204,5 k € | -11.0% | 229,8 k € | +1.9% | 225,6 k € | -10.8% | 252,9 k € | +78.3% | 141,9 k € | -21.1% | 179,7 k € | -3.6% | 186,5 k € | +7.6% | 173,4 k € | +15.4% | 150,3 k € | +610% | 21,2 k € | -23.0% | 27,5 k € | +12.1% | 24,5 k € | +7.5% | 22,8 k € | +37.4% | 16,6 k € | -3.4% | 17,2 k € |
| Balance sheet | |||||||||||||||||||||||||||||||
| Equity | 2,1 M € | +11.7% | 1,9 M € | +12.1% | 1,7 M € | +15.7% | 1,5 M € | +18.3% | 1,2 M € | +25.8% | 981,5 k € | +16.9% | 839,6 k € | +28.4% | 653,9 k € | +39.9% | 467,4 k € | +59.5% | 293 k € | +105% | 142,7 k € | +17.4% | 121,5 k € | +29.2% | 94,1 k € | +35.2% | 69,6 k € | +48.7% | 46,8 k € | +55.0% | 30,2 k € |
| Total assets | 3,6 M € | +0.3% | 3,6 M € | +0.7% | 3,6 M € | +0.7% | 3,5 M € | +1.2% | 3,5 M € | -0.4% | 3,5 M € | +4.3% | 3,4 M € | +5.9% | 3,2 M € | -0.9% | 3,2 M € | +4.7% | 3,1 M € | +0.4% | 3,1 M € | +1995% | 145,9 k € | +21.2% | 120,4 k € | +61.1% | 74,7 k € | +34.2% | 55,7 k € | +37.8% | 40,4 k € |
| Cash | 220,8 k € | -7.8% | 239,5 k € | +60.6% | 149,1 k € | -38.4% | 242,3 k € | +32.0% | 183,5 k € | -8.9% | 201,4 k € | +495% | 33,9 k € | -75.9% | 140,2 k € | -34.9% | 215,5 k € | +274% | 57,6 k € | +453% | 10,4 k € | -90.9% | 114,6 k € | +36.3% | 84 k € | +35.3% | 62,1 k € | +58.1% | 39,3 k € | +104% | 19,3 k € |
| Debts | 1,5 M € | -13.7% | 1,7 M € | -9.8% | 1,9 M € | -9.9% | 2,1 M € | -8.1% | 2,3 M € | -10.6% | 2,5 M € | +0.1% | 2,5 M € | +0.1% | 2,5 M € | -7.8% | 2,7 M € | -1.1% | 2,8 M € | -4.7% | 2,9 M € | +11861% | 24,4 k € | -7.4% | 26,3 k € | +410% | 5,2 k € | -42.2% | 8,9 k € | -12.8% | 10,2 k € |
| Other | |||||||||||||||||||||||||||||||
| Workforce | 0,0 ETP | – | 0,0 ETP | – | – | – | – | – | – | – | – | – | – | – | – | – | |||||||||||||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 8 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
APOTHEEK GLORIEUX● Active | 0420.109.869 |
Christine Van Laer● Active | 1033.867.372 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Micro model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/06/2026 | 18/07/2025 | 22/08/2024 | 28/06/2023 | 24/06/2022 | 28/06/2021 |
| General meeting | 10/06/2026 | 20/06/2025 | 20/06/2024 | 20/06/2023 | 20/06/2022 | 21/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
16 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 10/06/2026 | 22/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 20/06/2025 | 18/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 20/06/2024 | 22/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 20/06/2023 | 28/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 20/06/2022 | 24/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 21/06/2021 | 28/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 20/06/2020 | 29/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 20/06/2019 | 25/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 20/06/2018 | 28/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 20/06/2017 | 28/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 20/06/2016 | 28/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 20/06/2015 | 22/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 20/06/2014 | 03/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 20/06/2013 | 27/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 20/06/2012 | 25/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 20/06/2011 | 29/06/2011 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 8 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025222,3 k €↑
- 2024Annual accounts 2024204,5 k €↓
- 2023Annual accounts 2023229,8 k €↑
- 2022Annual accounts 2022225,6 k €↓
- 2021Annual accounts 2021252,9 k €↑
- 2020Annual accounts 2020141,9 k €↓
- 2019Annual accounts 2019179,7 k €↓
- 2018Annual accounts 2018186,5 k €↑
- 2017Annual accounts 2017173,4 k €↑
- 2016Annual accounts 2016150,3 k €↑
- 2015Annual accounts 201521,2 k €↓
- 2014Annual accounts 201427,5 k €↑
- 2013Annual accounts 201324,5 k €↑
- 2012Annual accounts 201222,8 k €↑
- 2011Annual accounts 201116,6 k €↓
- 2010Annual accounts 201017,2 k €
- 28/09/2009IncorporationPrivate limited company